eprintid: 10131360
rev_number: 26
eprint_status: archive
userid: 608
dir: disk0/10/13/13/60
datestamp: 2021-07-19 13:09:57
lastmod: 2022-06-30 16:30:36
status_changed: 2021-07-19 13:09:57
type: article
metadata_visibility: show
creators_name: Appleyard, SE
creators_name: Larkin, MJW
creators_name: Stewart, EM
creators_name: Minton, O
creators_name: Gilbert, DC
title: Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment
ispublished: pub
divisions: UCL
divisions: B02
divisions: D65
divisions: J38
keywords: Electronic patient-reported outcome measures, patient-reported outcome measures, prostate cancer, quality of life
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
abstract: AIMS: Electronic patient-reported outcome (ePRO) measures have the potential to improve patient care, both at an individual level by detecting symptoms and at an organisational level to rationalise follow-up. The introduction of ePROs has many challenges, including funding, institutional rigidity and acceptability for both patients and clinicians. There are multiple examples of successful ePRO programmes but no specific feasibility studies in those who are less digitally engaged. Prostate cancer is predominantly a disease of older men and digital exclusion is associated with increased age. We assessed the feasibility of ePRO completion in older men receiving treatment for advanced prostate cancer both within the clinic and from home. MATERIALS AND METHODS: Men receiving palliative systemic treatment were asked to complete ePROs on a tablet computer in the outpatient department at 0 and 3 months. Participants were also offered optional completion from home. Feasibility was assessed via a mixed methods approach. RESULTS: On-site ePRO completion was acceptable to most patients, with 90% finding it easy or straightforward and 80% preferring electronic over paper. Remote completion was more challenging, even for those who accessed e-mail daily and owned a tablet, with only 20% of participants successfully completing ePROs. Barriers to electronic completion can be categorised as technical, attitudinal and medical. Quality of life and symptom ePRO results were comparable with published data. CONCLUSIONS: On-site completion is achievable in this population with limited staff support. However, remote completion requires further work to improve systems and acceptability for patients. Remote completion is critical to add significantly to current clinical care by detecting symptoms or stratifying follow-up.
date: 2021-12-01
date_type: published
official_url: https://doi.org/10.1016/j.clon.2021.04.008
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1872482
doi: 10.1016/j.clon.2021.04.008
pii: S0936-6555(21)00157-6
lyricists_name: Gilbert, Duncan
lyricists_id: DGILB61
actors_name: Zahnhausen-Stuber, Petra
actors_id: PMZAH20
actors_role: owner
full_text_status: public
publication: Clinical Oncology
volume: 33
number: 12
pagerange: 751-760
event_location: England
citation:        Appleyard, SE;    Larkin, MJW;    Stewart, EM;    Minton, O;    Gilbert, DC;      (2021)    Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment.                   Clinical Oncology , 33  (12)   pp. 751-760.    10.1016/j.clon.2021.04.008 <https://doi.org/10.1016/j.clon.2021.04.008>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10131360/3/Gilbert_Manuscript%20-%20Digital%20Medicine%20in%20Prostate%20Cancer%20-%20revision.pdf